TABLE 1.
LMHFV effects on mesenchymal stem cells.
| References | Cells | Environment | Frequency (Hz) | Magnitude (*g) | Time schedule | Main outcome |
| Baskan et al., 2017 | D1-ORL-UVA | TCP | 90 | 0.15 | 15 min/day 7 days | Adipogenic markers ↓ |
| Chen et al., 2016 | rBMSCs | HA-coated titanium scaffolds (3D) | 40 | 0.3 | 30 min/day 14 days | Expression of osteogenic markers (Runx2, Osx, Col-1, OC) ↑ |
| Demiray and Özçivici, 2015 | D1-ORL-UVA | TCP | 90 | 0.15 | 15 min/day for 7 days | Cytoskeletal adaptations: total actin content and actin fiber thickness ↑ Cell proliferation ↑ |
| Lau E. et al., 2011 | rMSCs | TCP | 60 | 0.3 | 1 h/day on days 1 + 2 and 4–6 | Osteogenesis ↓ |
| Li et al., 2019 | rBMSCs | TCP (not stated) | 45 | 0.9 | 30 min/day 5 days | Expression of osteogenic markers (Runx2, Osx, Col-1, OCN) ↑ |
| Lu et al., 2018 | BMSCs | TCP (not stated) | 40 | 0.3 | 15 min/day | Cell proliferation and mineralization ↑ Expression of osteogenic markers (Runx2, Col-I, ALP, OPN, OC) ↑ |
| Marycz et al., 2016 | hASCs | TCP | 25, 35, 45 | 0.3 | 15 min/day 14 days | Expression of osteogenic and chondrogenic markers (BMP-2, Col-II, Sox9) ↑ Adipogenesis ↓ |
| Mehta, 2015 | hMSCs | Synthetic 3D scaffold (PEGDA) | 100 | 0.3 3 6 | 24 h | Osteogenic differentiation (ALP) and mineralization ↑ |
| Kim et al., 2012 | hMSCs | Collagen sponge (3D scaffold), TCP | 30–40 | 0.3 | 10 min/day 5 days | Expression of osteogenic and vascularization-related markers (Col-I, OPG, VEGF, VEGF) ↑ |
| Pongkitwitoon et al., 2016 | hBMCs | TCP | 30 or 100 | 0.15 1 | 2 × 20 min/day (2 h rest period) | Cell proliferation ↑ Expression of osteogenic markers (Runx2, ALP) ↑ |
| Uzer et al., 2013 | hASCs | TCP | 30 or 100 | 0.15 1 2 | 30 min/day | Cell proliferation and mineralization ↑ Cytoskeletal remodeling ↑ |
| Uzer et al., 2015 | mBMSCs | TCP or collagen-I coated plates | 90 | 0.7 | 2 × 20 min/day | Cytoskeletal remodeling ↑ |
| Zhou et al., 2011 | BMSCs | Human bone-derived scaffolds (3D) | 40 | 0.3 | 30 min/12 h | Expression of osteogenic markers (Col-I, OCN, ALP, Runx2) ↑ ERK1/2 pathway involved |